Antonia M. Davidson

Publications

Citations

H-Index

2018

Active since

Affiliations

Pharmaceutical Product Development (United States)(Current)

Antonia M. Davidson is an author at Pharmaceutical Product Development (United States) specializing in medicine, pharmacokinetics, and clinical pharmacology.

Top concepts

MedicinePharmacologyPharmacotherapyPharmacokineticsClinical PharmacologyHivClinical TrialsDrug ResistanceMolecular PharmacologyPharmacodynamic Modeling

Publications per year

2018–2021

Publications

A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants

Teodora Pene Dumitrescu, Samit R. Joshi, Jianfeng Xu et al. · Antimicrobial Agents and Chemotherapy · 2021 · 17 citations · Full text

Steady-state Pk, Pharmacotherapy, Antiviral Drug +20

Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects

Anne Gardin, Cathy Gray, Srikanth Neelakantham et al. · European Journal of Clinical Pharmacology · 2018 · 14 citations

Molecular Pharmacology, Healthy Subjects, Siponimod Pharmacokinetics +8

Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects

Antonia M. Davidson, Darin Brimhall, Jonathan Kay et al. · British Journal of Clinical Pharmacology · 2021 · 12 citations · Full text

Rows per page

1–3 of 3